We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Editorial | 
Timothy W. Olsen, MD
JAMA. 2015;314(20):2135-2136. doi:10.1001/jama.2015.15409.

Original Investigation |  FREE
Writing Committee for the Diabetic Retinopathy Clinical Research Network
JAMA. 2015;314(20):2137-2146. doi:10.1001/jama.2015.15217.
Includes: CME, Supplemental Content

Health Agencies Update | 
Julie A. Jacob, MA
JAMA. 2015;314(20):2121. doi:10.1001/jama.2015.15305.

From The Medical Letter on Drugs and Therapeutics | 
JAMA. 2015;314(20):2184-2185. doi:10.1001/jama.2015.15427.

JAMA Patient Page |  FREE
Aria A. Razmaria, MD, MSc
JAMA. 2015;314(20):2202. doi:10.1001/jama.2015.15899.

News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2015;314(17):1789. doi:10.1001/jama.2015.13699.

From the JAMA Network | 
Sandeep Vijan, MD, MS; Angela Fagerlin, PhD
JAMA. 2015;314(17):1861-1862. doi:10.1001/jama.2015.11518.

Editorial | 
J. Michael McGinnis, MD, MPP
JAMA. 2015;314(16):1699-1700. doi:10.1001/jama.2015.12391.

Original Investigation | 
Jiemin Ma, PhD, MHS; Elizabeth M. Ward, PhD; Rebecca L. Siegel, MPH; et al.
JAMA. 2015;314(16):1731-1739. doi:10.1001/jama.2015.12319.
Includes: CME, Supplemental Content

News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2015;314(15):1554. doi:10.1001/jama.2015.13009.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Ophthalmology
Invited Commentary  | 
Drilling Deeper for Treatment Choices in Diabetic Macular Edema
Emily Y. Chew, MD
JAMA Ophthalmology
Original Investigation  | 
Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
John A. Wells, MD; Adam R. Glassman, MS; Lee M. Jampol, MD; et al.
JAMA Ophthalmology
Invited Commentary  | 
Vitrectomy for Proliferative Diabetic Retinopathy Does Anyone Know the Complication Rate?
David J. Browning, MD, PhD
JAMA Ophthalmology
Original Investigation  | 
Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort
Writing Team for the DCCT/EDIC Research Group